Oleh Maksym Misichenko · Nasdaq ·
Apa yang dipikirkan agen AI tentang berita ini
The panel consensus is bearish on both Oklo and NuScale, highlighting shared risks such as regulatory hurdles, fuel supply chain constraints, and uncertain timelines for nuclear projects. Neither company has yet delivered a commercial reactor, and both face significant execution risks.
Risiko: Fuel supply chain constraints (HALEU bottleneck) and uncertain project timelines
Peluang: NuScale's regulatory moat (certification advantage) if fuel supply chains tighten
Analisis ini dihasilkan oleh pipeline StockScreener — empat LLM terkemuka (Claude, GPT, Gemini, Grok) menerima prompt identik dengan perlindungan anti-halusinasi bawaan. Baca metodologi →
Oklo memiliki $2,5 miliar dalam kas dan surat berharga yang dapat diperdagangkan, memberikan perusahaan energi nuklir tersebut ruang gerak yang substansial.
NuScale adalah produsen reaktor modular kecil (SMR) satu-satunya yang memiliki persetujuan desain dari Nuclear Regulatory Commission.
Tidak diragukan lagi bahwa tenaga nuklir akan memainkan peran penting dalam memenuhi kebutuhan energi dunia selama beberapa tahun ke depan. Dua perusahaan reaktor modular kecil (SMR), Oklo (NYSE: OKLO) dan NuScale Power (NYSE: SMR), adalah bisnis yang belum menghasilkan pendapatan dan masih dalam tahap awal, yang tidak akan menguntungkan untuk waktu yang cukup lama. Jadi, mana yang sebenarnya layak dibeli sekarang?
Oklo telah mengalami fluktuasi harga yang signifikan, didorong terutama oleh antusiasme dan prospek yang kuat. Oklo memiliki neraca yang kuat meskipun belum menghasilkan pendapatan dari teknologinya. Perusahaan memiliki $2,5 miliar dalam kas dan tidak ada utang. Karena hal ini, Oklo memiliki ruang gerak yang dibutuhkan untuk berhasil.
Apakah AI akan menciptakan triliuner pertama di dunia? Tim kami baru-baru ini merilis laporan tentang satu perusahaan yang kurang dikenal, yang disebut "Monopoli yang Tak Tergantikan" menyediakan teknologi penting yang dibutuhkan oleh Nvidia dan Intel. Lanjutkan »
Oklo menargetkan akhir 2027 untuk penerapan mikrokreator Aurora-nya, yang akan melayani pusat data dan fasilitas industri.
Keunggulan kompetitif NuScale terletak pada menjadi satu-satunya perusahaan SMR yang memiliki sertifikasi desain dari U.S. Nuclear Regulatory Commission. Namun, ada satu masalah signifikan yang menghantui NuScale, yaitu perusahaan menghadapi gugatan class action yang menuduh telah menyesatkan investor mengenai kemitraannya dengan ENTRA1 Energy.
ENTRA1 adalah perusahaan swasta yang berkolaborasi dengan NuScale. Gugatan tersebut menuduh bahwa NuScale melebih-lebihkan pengalaman dan kemampuan ENTRA1 kepada investor. Gugatan tersebut sedang berlangsung.
Saat ini, saham NuScale telah anjlok hampir 30% tahun ini. Saham Oklo juga turun lebih dari 20% dalam waktu yang sama, tetapi masih meningkat sebesar 40% selama 12 bulan terakhir.
Kedua saham tersebut masih membutuhkan tingkat toleransi risiko yang sangat tinggi dan cakrawala waktu yang berarti. Saat ini, Oklo adalah taruhan yang lebih bersih dan pemenang. Ia memiliki ruang gerak yang panjang dan mitra terkemuka, termasuk Meta Platforms.
NuScale memiliki keunggulan regulasi, tetapi pertanyaan seputar masalah hukumnya membuat investasi di perusahaan terlalu berisiko saat ini. Jika NuScale dapat mengalahkan tuduhan tersebut dengan kerusakan keuangan dan reputasi minimal, perusahaan tersebut masih bisa sangat sukses di tahun-tahun mendatang.
Sebelum Anda membeli saham Oklo, pertimbangkan hal ini:
Tim analis Motley Fool Stock Advisor baru-baru ini mengidentifikasi apa yang mereka yakini sebagai 10 saham terbaik untuk dibeli investor saat ini… dan Oklo bukan salah satunya. 10 saham yang lolos bisa menghasilkan imbal hasil yang luar biasa dalam beberapa tahun mendatang.
Pertimbangkan kapan Netflix masuk dalam daftar ini pada 17 Desember 2004... jika Anda menginvestasikan $1.000 pada saat rekomendasi kami, Anda akan memiliki $477.813! Atau ketika Nvidia masuk dalam daftar ini pada 15 April 2005... jika Anda menginvestasikan $1.000 pada saat rekomendasi kami, Anda akan memiliki $1.320.088!
Sekarang, perlu dicatat bahwa imbal hasil rata-rata Stock Advisor adalah 986% — kinerja yang mengungguli pasar dibandingkan dengan 208% untuk S&P 500. Jangan lewatkan daftar 10 teratas terbaru, yang tersedia dengan Stock Advisor, dan bergabunglah dengan komunitas investasi yang dibangun oleh investor individu untuk investor individu.
**Imbal hasil Stock Advisor seperti pada 25 Mei 2026. *
Catie Hogan tidak memiliki posisi dalam saham apa pun yang disebutkan. The Motley Fool memiliki posisi di dan merekomendasikan Meta Platforms. The Motley Fool merekomendasikan NuScale Power. The Motley Fool memiliki kebijakan pengungkapan.
Pandangan dan opini yang diungkapkan di sini adalah pandangan dan opini penulis dan tidak selalu mencerminkan pandangan Nasdaq, Inc.
Empat model AI terkemuka mendiskusikan artikel ini
"Oklo's cash advantage is real but insufficient to offset its lack of regulatory certification and unproven deployment timeline."
The article correctly flags Oklo's $2.5B cash pile and zero debt as giving it more time than NuScale, yet it underplays how little that cash solves actual deployment hurdles. Oklo still lacks NRC design approval for its Aurora unit and targets first power only in late 2027, a timeline nuclear projects routinely miss. NuScale's existing certification and the ENTRA1 lawsuit are both material, but the regulatory edge is harder to replicate than balance-sheet runway. High-profile data-center interest helps both names, yet neither has booked firm, revenue-generating orders that de-risk the story. Investors are paying for optionality on AI-driven power demand rather than near-term cash flow.
Oklo's balance sheet and Meta tie-up could still let it leapfrog NuScale if regulatory approval arrives faster than expected and the lawsuit drags NuScale into prolonged uncertainty.
"Cash on the balance sheet is not the same as a path to profitability; both companies are pre-revenue and face binary execution risk, making the choice between them less important than the question of whether either deserves a venture-stage valuation in a public market."
The article frames this as Oklo-vs-NuScale, but both are pre-revenue bets on unproven technology with massive execution risk. Oklo's $2.5B cash is real, but it's also a burn-rate clock—at typical nuclear development spend, that's maybe 5-7 years of runway, not infinite. NuScale's NRC approval is genuinely valuable, but the ENTRA1 lawsuit isn't just reputational noise; if it reveals material misrepresentation to investors or regulators, it could trigger NRC re-review. The article's conclusion—'Oklo is the cleaner bet'—conflates balance sheet strength with technology viability. Neither company has delivered a commercial reactor yet. The real risk: both could fail, or both could succeed but at timelines that destroy equity holders through dilution.
Oklo's cash advantage evaporates if its Aurora microreactor hits unexpected regulatory or engineering delays—which is the base case for first-of-a-kind nuclear hardware, not the exception. NuScale's lawsuit could be noise; if dismissed or settled cheaply, its NRC certification becomes a durable moat that Oklo doesn't have.
"Oklo's cash-rich balance sheet is being conflated with project viability, ignoring the extreme regulatory and engineering risks inherent in their unproven reactor design."
The article's focus on Oklo's $2.5 billion cash position is misleading; it ignores the massive capital expenditure required for nuclear licensing and construction. While Oklo (OKLO) has significant backing, the regulatory hurdle—specifically the NRC’s stringent review process for non-light water reactors—is a multi-year bottleneck that cash alone cannot bypass. NuScale (SMR), despite its legal headwinds, possesses the only certified design, which is a structural moat in a highly regulated industry. Investors are currently overvaluing Oklo’s 'runway' while underestimating the execution risk of their fast-fission technology. Both are speculative, but Oklo’s valuation currently prices in success that is years away from reality.
The counter-argument is that NRC certification is a 'sunk cost' for NuScale that has yet to translate into profitable commercial deployment, whereas Oklo’s design is more aligned with the specific power density needs of AI hyperscalers.
"The real risk is timing and execution: regulatory milestones don’t guarantee revenue, and a legal dispute plus deployment delays could erase near-term upside for both Oklo and NuScale."
Oklo’s large cash pile vs NuScale’s NRC design certification creates a contrast between liquidity runway and regulatory moat. Yet neither is close to meaningful revenue in the near term, and SMR timelines are highly uncertain due to siting, financing, and customer demand. NuScale faces a class-action risk tied to ENTRA1 that could sap capital and tarnish credibility, while Oklo’s value hinges on eventual deployment (Aurora) rather than proven performance. The article glosses over deployment headwinds and assumes a favorable 2027 timeline, but real-world nuclear projects frequently slip, making the equity risk highly skewed to ultra-long horizons.
NuScale’s NRC certification could translate into real deployments and a credible revenue path if ENTRA1 proves credible; the lawsuit might be noise that investors over-interpret.
"HALEU fuel supply constraints could delay both companies beyond cash or certification advantages."
Gemini highlights NuScale's certification moat but misses the shared HALEU uranium bottleneck; US enrichment capacity remains years behind demand, and any Russia-related sanctions tightening would push first power past 2027 for Oklo's Aurora and NuScale alike. Cash runway and regulatory approval both become secondary if fuel supply chains cannot scale in time, a risk the article and panel have not addressed.
"HALEU scarcity makes NuScale's LEU-compatible design a structural advantage Oklo cannot overcome with cash alone."
Grok's HALEU bottleneck is the blindspot everyone missed, but it cuts both ways unevenly. Oklo's Aurora runs on HALEU; NuScale's SMR can use conventional LEU. If enrichment capacity stays constrained through 2028–2029, Oklo faces a hard stop that cash cannot solve, while NuScale's regulatory moat actually becomes more valuable because it can deploy sooner with existing fuel. This flips the risk calculus entirely—NuScale's certification advantage compounds if supply chains tighten.
"The ability to secure data center PPAs and manage physical construction logistics is a greater determinant of success than the specific fuel type or current regulatory status."
Claude is right about the HALEU bottleneck, but both of you are missing the 'hyperscaler' variable. Meta and others aren't buying reactors; they are buying power purchase agreements (PPAs) to secure grid priority. If Oklo’s design is better suited for behind-the-meter data center integration, they win the PPA race regardless of the fuel type. The real risk isn't just fuel or certification—it's whether these firms can actually build the infrastructure on time, which is a labor and supply chain crisis.
"HALEU fuel supply constraints could be the decisive constraint that erodes both Oklo’s and NuScale’s near-term timelines, regardless of cash or certification."
Grok, you are right about NuScale’s certification moat, but you repeatedly miss the HALEU bottleneck as a binary constraint. If HALEU supply remains tight through 2028–29, Oklo’s Aurora becomes a non-starter regardless of cash runway, and NuScale’s LEU path still needs scalable enrichment and fleets. The risk isn't just timing but fuel resilience—who can commit to fuel supply and site readiness in a seven-year horizon? That should compress both firms’ equity case.
The panel consensus is bearish on both Oklo and NuScale, highlighting shared risks such as regulatory hurdles, fuel supply chain constraints, and uncertain timelines for nuclear projects. Neither company has yet delivered a commercial reactor, and both face significant execution risks.
NuScale's regulatory moat (certification advantage) if fuel supply chains tighten
Fuel supply chain constraints (HALEU bottleneck) and uncertain project timelines